PGY-1

2023-2024

  • Human Herpesvirus 6 (HHV-6) Encephalitis in Immunocompetent Patients

2022-2023

  • Incidence of Behavioral Side Effects with Brivaracetam in Children and Adolescents
  • Evaluation of Octreotide Safety and Efficacy for Chylothorax in Pediatric Patients

2021-2022

  • Evaluation of Pain Control Between Verbal and Non-verbal Cerebral Palsy Patients During a 24-hour Post-Operative Period
  • Evaluation of REGEN-COV (casirivimab and imdevimab ) use in pediatric patients for the treatment of mild to moderate COVID-19 disease

2020-2021

  • Incidence of hyponatremia with the use of vasopressin in pediatric patients
  • Evaluation of advancing chemotherapy administration times and the incidence of hemorrhagic cystitis/hematuria

2019-2020

  • Utilization of Intravenous Clonidine in a Neonatal Intensive Care Unit
  • Retrospective review of IVIG usage and potential cost savings analysis at a children's hospital

2018-2017

  • Evaluation of Advancing Chemotherapy Administration Times and the Incidence of Hemorrhagic Cystitis
  • Evaluation of peri-extubation propofol washout in critically ill children undergoing prolonged mechanical ventilation

2017-2018

  • Retrospective analysis of opioid rotation strategies in the pediatric intensive care unit
  • Retrospective Evaluation of Empiric Vancomycin Dosing at a Children’s Hospital

2016-2017

  • Incidence of hyponatremia with the use of vasopressin in pediatric patients

2015-2016

  • Impact of Medication Education Service by Pharmacy Interns on HCAHPS Scores in a Pediatric Hospital
  • Retrospective Review of Auto-verified Orders in a Pediatric Emergency Department Before and After Pharmacist-driven Provider Education

PGY-2

2023-2024

  • Efficacy and safety of midodrine in critically ill pediatric patients

2022-2023

  • Evaluations of Clinical and Bacteriological Outcomes of Vancomycin AUC/MIC Monitoring in Pediatric Patients Treated for Organisms other than Methicillin-Resistant Staphylococcus aureus (MRSA)